Zulaikha Akbar

Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants

Christopher Allen, Y. Takeuchi, Alexander Kinna, 2021, Journal of virology.

Characterization of a Novel ACE2-Based Therapeutic with Enhanced Rather than Reduced Activity against SARS-CoV-2 Variants

Christopher Allen, Y. Takeuchi, Alexander Kinna, 2021, bioRxiv.

Optimised Method for the Production and Titration of Lentiviral Vectors Pseudotyped with the SARS-CoV-2 Spike.

Y. Takeuchi, G. Mattiuzzo, E. Bentley, 2021, Bio-protocol.

Abstract 2183: Targeting TRBC1 and 2 for the treatment of T cell lymphomas

S. Onuoha, M. Pule, P. Wawrzyniecka, 2020 .

A tetrameric ACE2 protein broadly neutralizes SARS-CoV-2 spike variants of concern with elevated potency

T. Rabbitts, Ami Miller, Hanif Ali, 2021, Antiviral Research.

Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

R. Reijmers, M. Al-Hajj, S. Onuoha, 2023, Journal for immunotherapy of cancer.

Limited efficacy of APRIL CAR in patients with multiple myeloma indicate challenges in the use of natural ligands for CAR T-cell therapy

R. Reijmers, M. Al-Hajj, K. Yong, 2023, Journal for ImmunoTherapy of Cancer.

Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry

Janosch Ortmann, M. Ferrari, P. Maciocia, 2023, medRxiv.